ESG

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.

A deep dive into the 15-year partnership between Viva Energy and ISN, exploring how technology and collaboration are setting new safety benchmarks in Australia.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

Amid surging investor confidence, Copper Road Resources has twice increased its private placement, securing nearly $1M for critical mineral exploration in Ontario.

As the market for oral supplements explodes, products like Synadentix promise a healthier mouth. But does the science back the billion-dollar marketing?

A new report projects 27.5% annual growth for automotive AI, fueled by smart cars, government backing, and a fierce race for market dominance.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

How decades-old industrial equipment is challenging modern concepts of value, forcing a re-evaluation of sustainability and long-term investment strategy.

YXT.com's $100M shelf registration gives it a war chest for AI growth, but investors weigh the promise of innovation against current financial pressures.